United Kingdom · Venture startup
Funding summaryUpdated 26 Oct 2026
$9.6Mraised across 8 rounds since 2021, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Neo Kuma VenturesLead
Wren Capital
O2h VenturesShares issued, filed with Companies House (SH01); no report of this raise yet and 1 other
Monument Therapeutics filed 9 raises, $9.6M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Monument Therapeutics's own website: 4 on the team.
AdvisersDr Mark Treherne
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Neo Kuma VenturesL
Innovate UK
SyndicateRoom
ACF Investors
Cambridge AngelsWren CapitalO2h VenturesMissing a round, or an investor who was in one? Tell us.
Monument Therapeutics's investors include Catapult Ventures' Greater Manchester and Cheshire Life Sciences Fund, Neo Kuma Ventures, Innovate UK, SyndicateRoom and ACF Investors, and 3 more on record.
Monument Therapeutics has raised $9.6M across 8 rounds since 2021. One round did not disclose an amount, so the total is a floor.
Monument Therapeutics's most recent round, $1.7M, was in Jun 2026.
Monument Therapeutics's largest round on record is $3.6M (Seed), in Jun 2021, led by Catapult Ventures' Greater Manchester and Cheshire Life Sciences Fund.
Monument Therapeutics's first round on record, in Jun 2021, was backed by Catapult Ventures' Greater Manchester and Cheshire Life Sciences Fund, Neo Kuma Ventures and Wren Capital and 1 others.
Monument Therapeutics's latest named round is a Venture, in Feb 2026.
Monument Therapeutics is based in the United Kingdom.
Catapult Ventures' Greater Manchester and Cheshire Life Sciences Fund led the Seed in 2021.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
